|
|
|
Insider
Information: |
Prange Karen |
Relationship: |
Director |
City: |
Natick |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
192,870 |
|
Indirect Shares
|
1,000 |
|
|
Direct
Value |
$8,430,949 |
|
|
Indirect Value
|
$77,110 |
|
|
Total
Shares |
193,870 |
|
|
Total
Value |
$8,508,059 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
3
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
1.0
|
-3.0
|
Percentage
Gain/Loss : |
75.9%
|
-228.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Boston Scientific Corp |
BSX |
SVP&Pres, Uro & Pelvic... |
2016-03-08 |
38,395 |
2016-03-08 |
1,000 |
Premium* |
|
Henry Schein Inc |
HSIC |
EVP&CEO Gl.AH.Med.Den.... |
2018-03-02 |
62,902 |
2016-06-10 |
0 |
Premium* |
|
Atricure, Inc. |
ATRC |
Director |
2024-05-13 |
23,928 |
2019-12-04 |
0 |
Premium* |
|
Nevro Corp |
NVRO |
|
2024-05-23 |
33,948 |
2019-12-17 |
0 |
Premium* |
|
Cantel Medical Corp |
CMN |
Director |
2021-06-02 |
0 |
2020-07-31 |
0 |
Premium* |
|
Viewray, Inc. |
VRAY |
Director |
2023-07-21 |
8,799 |
2021-07-01 |
0 |
Premium* |
|
Embecta Corp. |
EMBC |
Director |
2024-02-07 |
24,898 |
2022-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
53 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ATRC |
Atricure, Inc. |
Director |
|
2019-12-04 |
4 |
A |
$0.00 |
$0 |
D/D |
5,902 |
5,902 |
0 |
- |
|
ATRC |
Atricure, Inc. |
Director |
|
2020-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,452 |
8,354 |
0 |
- |
|
ATRC |
Atricure, Inc. |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,749 |
10,103 |
0 |
- |
|
ATRC |
Atricure, Inc. |
Director |
|
2022-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,564 |
13,667 |
0 |
- |
|
ATRC |
Atricure, Inc. |
Director |
|
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,186 |
16,853 |
0 |
- |
|
ATRC |
Atricure, Inc. |
Director |
|
2023-06-08 |
4 |
S |
$47.89 |
$34,146 |
D/D |
(713) |
16,140 |
0 |
% |
|
ATRC |
Atricure, Inc. |
Director |
|
2024-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
7,788 |
23,928 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens HealthO |
|
2013-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,000 |
|
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
|
2013-07-02 |
4 |
D |
$9.17 |
$77,321 |
D/D |
(8,432) |
17,430 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
|
2013-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,862 |
25,862 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
|
2014-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,721 |
21,151 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
|
2014-02-28 |
4 |
D |
$13.10 |
$18,484 |
D/D |
(1,411) |
19,740 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
|
2014-07-02 |
4 |
D |
$13.13 |
$110,541 |
D/D |
(8,419) |
37,183 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
|
2014-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,862 |
45,602 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
|
2014-12-10 |
4 |
AS |
$12.64 |
$249,607 |
D/D |
(19,753) |
17,430 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
|
2015-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,102 |
19,532 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
|
2015-02-24 |
4 |
D |
$16.62 |
$13,213 |
D/D |
(795) |
18,737 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
|
2015-02-27 |
4 |
AS |
$16.80 |
$21,963 |
D/D |
(1,307) |
17,430 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
|
2015-02-28 |
4 |
D |
$16.90 |
$20,770 |
D/D |
(1,229) |
19,922 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
|
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,721 |
21,151 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
|
2015-03-03 |
4 |
AS |
$16.79 |
$41,838 |
D/D |
(2,492) |
17,430 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
|
2015-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,862 |
43,292 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
|
2015-07-02 |
4 |
D |
$17.57 |
$147,693 |
D/D |
(8,406) |
34,886 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
|
2015-07-07 |
4 |
AS |
$17.66 |
$308,308 |
D/D |
(17,456) |
17,430 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Pelvic Health |
|
2016-01-01 |
4 |
D |
$18.44 |
$118,625 |
D/D |
(6,433) |
29,863 |
0 |
- |
|
53 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|